- Home
- LANC vs VANI Comparison
LANC vs VANI Comparison
Compare LANC & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LANC
- VANI
- Stock Information
- Founded
- LANC 1961
- VANI 1998
- Country
- LANC United States
- VANI United States
- Employees
- LANC N/A
- VANI N/A
- Industry
- LANC Packaged Foods
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- LANC Consumer Staples
- VANI Health Care
- Exchange
- LANC Nasdaq
- VANI Nasdaq
- Market Cap
- LANC N/A
- VANI 68.1M
- IPO Year
- LANC N/A
- VANI 2014
- Fundamental
- Price
- LANC $180.02
- VANI $1.26
- Analyst Decision
- LANC Buy
- VANI Strong Buy
- Analyst Count
- LANC 4
- VANI 1
- Target Price
- LANC $209.67
- VANI $4.00
- AVG Volume (30 Days)
- LANC 166.2K
- VANI 146.6K
- Earning Date
- LANC 08-21-2025
- VANI 08-12-2025
- Dividend Yield
- LANC 2.20%
- VANI N/A
- EPS Growth
- LANC 27.36
- VANI N/A
- EPS
- LANC 6.15
- VANI N/A
- Revenue
- LANC $1,886,520,000.00
- VANI N/A
- Revenue This Year
- LANC $3.16
- VANI N/A
- Revenue Next Year
- LANC $2.33
- VANI N/A
- P/E Ratio
- LANC $28.11
- VANI N/A
- Revenue Growth
- LANC 0.69
- VANI N/A
- 52 Week Low
- LANC $156.14
- VANI $0.91
- 52 Week High
- LANC $202.63
- VANI $1.50
- Technical
- Relative Strength Index (RSI)
- LANC 65.92
- VANI 58.97
- Support Level
- LANC $165.16
- VANI $1.24
- Resistance Level
- LANC $184.36
- VANI $1.33
- Average True Range (ATR)
- LANC 4.35
- VANI 0.06
- MACD
- LANC 1.40
- VANI 0.00
- Stochastic Oscillator
- LANC 77.42
- VANI 59.09
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.